Abstract
Abstract
Purpose
Treatment of neuroblastoma metastases usually consists of chemotherapy and irradiation. However, in selected cases, surgical treatment is also indicated. In this study, we present three cases of patients with neuroblastoma metastases at rare sites that underwent surgery.
Materials and methods
We retrospectively analyzed data of patients who underwent surgery for neuroblastoma at our department of Pediatric Surgery and Pediatric Urology at the University Children’s Hospital in Tuebingen and selected those patients who had surgery explicitly for a metastasis.
Results
Between 2002 and 2020, 277 children underwent surgical treatment for neuroblastoma. Three cases with metastases at exceptional sites are presented here after therapy according to protocols. One patient had a penile metastasis and received surgery including a plastic reconstruction. The patient showed no signs of erectile or urinary dysfunction at follow-up. Another patient had a metastasis in the proximal ulna, which remained vital even after exhausted treatment after two relapses. Afterward there was no restriction of movement of the extremity. The third patient had, amongst others, metastases to the pancreatic body and to the liver. Both were surgically removed during primary tumor resection. This patient died after local tumor relapse. The other two patients showed no evidence of tumor relapse after a follow-up of 18 and 17 months, respectively.
Conclusion
Although children with neuroblastoma often present with metastases, there is no recommendation for surgical treatment other than diagnostic biopsies. In case of persistence of metastasis or after exhaustion of high-risk therapy, surgical resection must be considered.
Funder
Universitätsklinikum Tübingen
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference29 articles.
1. Berthold F (2004) NB2004 Trial protocol for risk adapted treatment of children with neuroblastoma. Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH). https://www.gpoh.de/sites/gpoh/kinderkrebsinfo/content/e1676/e9032/e68518/e206421/download7674/SeitenausNB_2004_1.00_klein_ger.pdf. Accessed 06 Jan 2023
2. Casey DL, Kushner BH, Cheung N-KV, Modak S, LaQuaglia MP, Wolden SL (2016) Local control with 21-Gy radiation therapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys 2:393–400
3. Casey DL, Kushner BH, Cheung NV, Modak S, LaQuaglia MP, Wolden SL (2018) Dose-escalation is needed for gross disease in high-risk neuroblastoma. Pediatr Blood Cancer 7:e27009. https://doi.org/10.1002/pbc.27009
4. Casey DL, Kushner BH, Cheung N-KV, Modak S, Basu EM, Roberts SS et al (2019) Reduced-dose radiation therapy to the primary site is effective for high-risk neuroblastoma: results from a prospective trial. Int J Radiat Oncol Biol Phys 2:409–414
5. DuBois SG, Kalika Y, Lukens JN, Brodeur GM, Seeger RC, Atkinson JB et al (1999) Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 3:181–189. https://doi.org/10.1097/00043426-199905000-00005